Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study

BACKGROUND: Ferric citrate hydrate (FC) is an oral iron-based phosphate binder that is used to treat hyperphosphatemia in patients with chronic kidney disease (CKD). This post-marketing surveillance study was performed to investigate the long-term safety and effectiveness of FC. METHODS: This prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Keitaro, Hashimoto, Teruo, Okuda, Yuri, Matsumoto, Yu, Ito, Kyoko, Yamada, Ryoichi, Susai, Hiroyuki, Nishino, Noriaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203387/
https://www.ncbi.nlm.nih.gov/pubmed/35258721
http://dx.doi.org/10.1007/s10157-022-02204-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203387/
https://www.ncbi.nlm.nih.gov/pubmed/35258721
http://dx.doi.org/10.1007/s10157-022-02204-1

Ejemplares similares